Last reviewed · How we verify
Xian-Hua-Cha — Competitive Intelligence Brief
phase 3
Immunology
Small molecule
Live · refreshed every 30 min
Target snapshot
Xian-Hua-Cha (Xian-Hua-Cha) — Chang Gung Memorial Hospital. Xian-Hua-Cha is a traditional Chinese herbal medicine that has been studied for its potential anti-inflammatory and antioxidant effects.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Xian-Hua-Cha TARGET | Xian-Hua-Cha | Chang Gung Memorial Hospital | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Xian-Hua-Cha CI watch — RSS
- Xian-Hua-Cha CI watch — Atom
- Xian-Hua-Cha CI watch — JSON
- Xian-Hua-Cha alone — RSS
Cite this brief
Drug Landscape (2026). Xian-Hua-Cha — Competitive Intelligence Brief. https://druglandscape.com/ci/xian-hua-cha. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab